Neurocrine
Showing 1 - 25 of 75
Congenital Adrenal Hyperplasia Trial in Worldwide (Crinecerfont, Placebo)
Recruiting
- Congenital Adrenal Hyperplasia
- Crinecerfont
- Placebo
-
Birmingham, Alabama
- +45 more
Dec 9, 2022
Epileptic Encephalopathy, Continuous Spike and Wave During Sleep Trial in Worldwide (NBI-827104, Placebo)
Completed
- Epileptic Encephalopathy
- Continuous Spike and Wave During Sleep
- NBI-827104
- Placebo
-
Orange, California
- +14 more
Nov 9, 2022
Tourette Syndrome Trial in Puerto Rico, United States (Valbenazine, Placebo oral capsule)
Terminated
- Tourette Syndrome
- Valbenazine
- Placebo oral capsule
-
Sun City, Arizona
- +48 more
Apr 26, 2022
Focal Onset Seizure, Focal Onset Epilepsy Trial in Worldwide (NBI-921352, Placebo)
Recruiting
- Focal Onset Seizure
- Focal Onset Epilepsy
- NBI-921352
- Placebo
-
Bruxelles, Belgium
- +20 more
May 17, 2022
Anhedonia, MDD Trial in Puerto Rico, United States (Placebo, NBI-1065846)
Recruiting
- Anhedonia
- Major Depressive Disorder
- Placebo
- NBI-1065846
-
Birmingham, Alabama
- +11 more
Jun 27, 2022
Congenital Adrenal Hyperplasia Trial in Worldwide (Crinecerfont, Placebo)
Recruiting
- Congenital Adrenal Hyperplasia
- Crinecerfont
- Placebo
-
Los Angeles, California
- +62 more
Apr 7, 2022
Epileptic Encephalopathy, Continuous Spike and Wave During Sleep Trial in Worldwide (NBI-827104)
Enrolling by invitation
- Epileptic Encephalopathy
- Continuous Spike and Wave During Sleep
-
Durham, North Carolina
- +5 more
Jul 14, 2022
CAH - Congenital Adrenal Hyperplasia Trial in United States (NBI-74788)
Completed
- CAH - Congenital Adrenal Hyperplasia
-
Aurora, Colorado
- +5 more
Apr 5, 2022
Drug-Induced Movement Disorder Trial in Burlington (Telemedicine Consult, In-person Consult)
Recruiting
- Drug-Induced Movement Disorder
- Telemedicine Consult
- In-person Consult
-
Burlington, VermontUniversity of Vermont Medical Center
Sep 23, 2023
Tourette Syndrome Trial in Puerto Rico, United States (Valbenazine, Placebo oral capsule)
Tardive Dyskinesia, Intellectual Disability, Developmental Disabilities Trial in Cleveland (Valbenazine Oral Capsule)
Not yet recruiting
- Tardive Dyskinesia
- +2 more
- Valbenazine Oral Capsule
-
Cleveland, OhioUniversity Hospitals of Cleveland
Oct 30, 2023
Tardive Dyskinesia (TD) Trial in Puerto Rico, United States (Valbenazine, Placebo oral capsule)
Completed
- Tardive Dyskinesia (TD)
- Valbenazine
- Placebo oral capsule
-
Little Rock, Arkansas
- +42 more
Mar 28, 2021
Essential Tremor Trial in Leiden (NBI-827104, Placebo)
Completed
- Essential Tremor
- NBI-827104
- Placebo
-
Leiden, CL, NetherlandsNeurocrine Clinical Site
Jul 8, 2022
Trichotillomania (Hair-Pulling Disorder) Trial in New Haven (Valbenazine Oral Capsule, Placebo Oral capsule)
Not yet recruiting
- Trichotillomania (Hair-Pulling Disorder)
- Valbenazine Oral Capsule
- Placebo Oral capsule
-
New Haven, ConnecticutYale Child Study Center
Jul 21, 2022
Dyskinesia, Cerebral Palsy Trial in Farmington Hills (Placebo, Valbenazine)
Recruiting
- Dyskinesia
- Cerebral Palsy
- Placebo
- Valbenazine
-
Farmington Hills, MichiganNeurocrine Clinical Site
Jun 27, 2022
Tardive Dyskinesia (TD) Trial in Puerto Rico, United States (Valbenazine, Placebo oral capsule)
Completed
- Tardive Dyskinesia (TD)
- Valbenazine
- Placebo oral capsule
-
Anaheim, California
- +16 more
May 27, 2020